MedPath

Proctozone-G

Proctozone-G Glycerin Suppositories 1.2 g

Approved
Approval ID

8a5c8ad5-3619-4971-967d-165270a20bc8

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 12, 2025

Manufacturers
FDA

Rising Pharma Holdings, Inc.

DUNS: 116880195

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glycerin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57237-338
Application NumberM007.54
Product Classification
M
Marketing Category
C200263
G
Generic Name
Glycerin
Product Specifications
Route of AdministrationRECTAL
Effective DateJune 12, 2025
FDA Product Classification

INGREDIENTS (3)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM STEARATEInactive
Code: QU7E2XA9TG
Classification: IACT
GLYCERINActive
Quantity: 1.2 g in 1 1
Code: PDC6A3C0OX
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 7/16/2025

NDC 57237-338-21 (2 blisters of 6 suppositories)

Proctozone-G****TM

GLYCERIN SUPPOSITORIES 1.2 g

RECTAL LAXATIVE

13011263 proctozone g 1.2 g carton-22.jpg

13011264 proctozone g 1.2 carton-1

Front Foil (57237-338-16)

12005007 proctozone g 1.2 g front foil

Back Foil (57237-338-16)

12005006 proctozone g 1.2 g back foil

NDC 57237-338-52 (5 blisters of 5 suppositories)

13011263 proctozone g 1.2 g carton-22.jpg

13011263 proctozone g 1.2 g carton-1

F****ront Foli (57237-338-51)

12005008 proctozone g front foil

B****ack Foil (57237-338-51)

12005012 proctozone g 1.2 g back foil

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 7/14/2025

Uses

  • For relief of occasional constipation
  • This product usually produces bowel movement in 1/4 to 1 hour

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 7/14/2025

Active ingredient (in each suppository)

Glycerin USP, 1.2 grams

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/16/2025

Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816

Made in India

Code No.: MH/DRUGS/25-KD/724

Issued: 05/2025

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 6/16/2025

Questions or Comments:

call 1-844-474-7464

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 7/14/2025

Purpose

Laxative

WARNINGS SECTION

LOINC: 34071-1Updated: 7/14/2025

Warnings

**For rectal use only**

Do not use for longer than 1 week unless directed by a doctor.

Ask a doctor before use if the child has

  • Stomach pain, nausea or vomiting
  • A sudden change in bowel habits lasting more than 2 weeks

When using this product your child may have rectal discomfort or a burning sensation

Stop use and ask a doctor if you have

  • Rectal bleeding
  • No bowel movement after using this product
    These may indicate a serious condition.

**Keep out of reach of children**

If swallowed, get medical help or contact a Poison Control Center right away.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 7/16/2025

Other Information

Keep away from excessive heat.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 7/16/2025

Directions

  • Tear off one suppository from the strip
  • If the suppository seems soft, place it in the refrigerator before use or run cold water over it before removing the foil wrapper
  • Gently remove suppository by peeling apart the wrapper** (see illustration 1)**
  • Rub a water-based lubricant over the tip or dip it in water. It will help you slide it in smoothly
  • Lie on your side and insert 1 suppository, tapered end first, about the length of your finger into the rectum** (see illustration 2)**
  • Hold the suppository for about 15-20 minutes to allow time for it to melt
  • Children 2 to under 6 years of age ...................... 1 suppository once daily
  • Children under 2 years ............................................ ask a doctor

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 7/16/2025

** Inactive ingredients**

purified water, sodium stearate.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.